intro
The GSK-Crick Prosperity Partnership is an EPSRC-funded collaborative initiative launched in 2021 between the Francis Crick Institute and GSK.
It was established in response to the urgent need to push the boundaries of drug discovery by targeting proteins previously considered 'undruggable'.
The partnership was born out of a shared vision to integrate cutting‐edge academic research with industry insight to develop a systems chemical biology platform capable of yielding actionable leads for disease-relevant targets.